Quantcast
Channel: Endpoints News
Viewing all articles
Browse latest Browse all 5860

SystImmune’s $250M milestone; Teva’s Uzedy approved to treat bipolar disorder

$
0
0
Plus, news about Avidity, Biophytis, the Novo Nordisk Foundation, ADC Therapeutics and Apogee Therapeutics: 💸 SystImmune to get $250M from Bristol Myers Squibb: The milestone payment is the result of the ...

Viewing all articles
Browse latest Browse all 5860

Trending Articles